arginine

ChEBI name None
PubChem name None
Names used in publications arginine, L-arginine hydrochloride

Datasets

Paper Phenotype Condition Medium Collection Tested mutants Data Details
Kim H~Cunningham KW, 2012 cell death (frequency of dead cells) tunicamycin [2.5 ug/ml] SC hap a 4,785 Quantitative
Cooper SJ~Fields S, 2010 abundance of a lysin-related metabolite standard SC hap a 2,021 Quantitative
Warringer J~Blomberg A, 2003 growth (exponential growth rate) sodium chloride [0.85 M] SC hap a 4,702 Quantitative
Warringer J~Blomberg A, 2003 growth (lag phase) sodium chloride [0.85 M] SC hap a 4,702 Quantitative
Warringer J~Blomberg A, 2003 growth (stationary phase cell density) sodium chloride [0.85 M] SC hap a 4,700 Quantitative
Hartman JL 4th~Tippery NP, 2004 growth (AUC) hydroxyurea [50 mM] SC hap a 4,700 Quantitative
Hartman JL 4th~Tippery NP, 2004 growth (AUC) hydroxyurea [150 mM] SC hap a 4,700 Quantitative
Willingham S~Muchowski PJ, 2003 growth (spot assay) expression of mutant huntingtin fragment [GAL] SC - Ura, Gal [2%] hap a ~4,850 Discrete
Xia L~Flores-Rozas H, 2007 growth (spot assay) doxorubicin [20 umol/L] SC hap a 4,802 Discrete
Gustavsson M~Ronne H, 2008 growth (spot assay) monensin A [50 uM] SC + Leu, ethanol [0.5%] hap alpha ~4,709 Discrete
Kakimoto M~Yoshimura E, 2005 growth (undefined) aluminium trichloride [0.2-1 mM] LPP (low-phosphate, pH 3.5) hap alpha ~4,826 Discrete
Fei W~Yang H, 2011 lipid particle size standard SC hap a ~4,800 Quantitative only for hits
Gupta SS~Rao R, 2003 growth (culture turbidity) amiodarone [7 uM] SC hap alpha ~5,000 Discrete
Ju D~Xie Y, 2008 abundance of a specific protein/peptide (Rpn4) standard SC - His hap a 4,802 Discrete
Gustavsson M~Ronne H, 2008 growth (spot assay) 5-fluorouracil [15 ug/mL] SC + Leu hap alpha ~4,676 Discrete
Wilson MA~van Hoof A, 2007 growth (undefined) standard SC - His hap a 4,785 Discrete
Hancock LC~Lopes JM, 2006 inositol excretion (inositol excretion) standard SC - Ino - Cho hap alpha 4,750 Discrete
Giorgini F~Muchowski PJ, 2005 growth (pooled CFU) expression of mutant huntingtin fragment [GAL] SC - Ura, Gal [2%] hap a 4,838 Discrete
Willingham S~Muchowski PJ, 2003 growth (spot assay) expression of alpha-sinuclein [unknown] SC - Ura + copper hap a ~4,850 Discrete
Kim H~Cunningham KW, 2012 cell death (frequency of dead cells) tacrolimus (anhydrous) [1 ug/ml], tunicamycin [2.5 ug/ml] SC hap a 4,785 Quantitative
Parsons AB~Boone C, 2004 growth (colony size) tacrolimus (anhydrous) [2 ug/ml] SC hap a ~4,700 Discrete
Parsons AB~Boone C, 2004 growth (colony size) cyclosporin A [100 ug/ml] SC hap a ~4,700 Discrete
Parsons AB~Boone C, 2004 growth (colony size) caffeine [0.15%] SC hap a ~4,700 Discrete
Parsons AB~Boone C, 2004 growth (colony size) sulfometuron methyl [3 ug/ml] SC hap a ~4,700 Discrete
Garay E~Deluna A, 2014 chronological lifespan standard SC hap a 3,878 Quantitative
Griffith JL~Devine SE, 2003 transposable element transposition (Ty1) standard SC - Ura, Gal [2%] hom 4,408 Discrete
Haugen AC~Van Houten B, 2004 growth (relative abundance in pooled culture) arsenic [1-5 mM] SC hom 4,741 Quantitative
Thorpe GW~Dawes IW, 2004 growth (spot assay) hydrogen peroxide [0.75–1.6 mM] SC hom ~4,546 Discrete
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) flucytosine [200 ng/mL] SC het 3,503 Quantitative only for hits
Ralser M~Lehrach H, 2008 growth (spot assay) 2-deoxy-D-glucose [0.20-0.25%] SC hap a 4,905 Discrete
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) 5-fluoro-2'-deoxyuridine [300 uM] SC het 3,503 Quantitative only for hits
Kang CM~Jiang YW, 2005 filamentous growth hydroxyurea [200 mM] SC hap a ~4,848 Discrete
Alvaro D~Rothstein R, 2007 mitotic recombination (frequency of Rad52 foci) standard SC - Leu hom 4,721 Quantitative
Johnson AJ~Wu MJ, 2015 growth (culture turbidity) sodium arsenite [0.2 mM] SC, pH 4.3 hom 4,870 Quantitative
Johnson AJ~Wu MJ, 2015 growth (culture turbidity) sodium arsenite [0.4 mM] SC, pH 4.3 hom 4,870 Quantitative
Giaever G~Johnston M, 2002 growth (relative abundance in pooled culture) time [5 gen] SC hom 4,715 Quantitative
Giaever G~Johnston M, 2002 growth (relative abundance in pooled culture) time [5 gen] SC - Lys hom 4,715 Quantitative
Giaever G~Johnston M, 2002 growth (relative abundance in pooled culture) time [5 gen] SC - Trp hom 4,715 Quantitative
Giaever G~Johnston M, 2002 growth (relative abundance in pooled culture) time [5 gen] SC - Thr hom 4,715 Quantitative
Cooper SJ~Fields S, 2010 abundance of arginine standard SC hap a 4,305 Quantitative
Cooper SJ~Fields S, 2010 abundance of biotin standard SC hap a 2,853 Quantitative
Cooper SJ~Fields S, 2010 abundance of N-acetyl ornithine standard SC hap a 3,318 Quantitative
Cooper SJ~Fields S, 2010 abundance of leucine + isoleucine + citrulline standard SC hap a 4,306 Quantitative
Cooper SJ~Fields S, 2010 abundance of glutamine + valine standard SC hap a 4,310 Quantitative
Cooper SJ~Fields S, 2010 abundance of methionine + proline standard SC hap a 4,297 Quantitative
Cooper SJ~Fields S, 2010 abundance of threonine standard SC hap a 3,980 Quantitative
Cooper SJ~Fields S, 2010 abundance of alanine standard SC hap a 4,309 Quantitative
Cooper SJ~Fields S, 2010 abundance of serine standard SC hap a 3,999 Quantitative
Cooper SJ~Fields S, 2010 abundance of asparagine + tyrosine standard SC hap a 4,304 Quantitative
Cooper SJ~Fields S, 2010 abundance of glycine standard SC hap a 4,305 Quantitative
Cooper SJ~Fields S, 2010 abundance of lysine standard SC hap a 4,309 Quantitative
Cooper SJ~Fields S, 2010 abundance of ornithine standard SC hap a 4,031 Quantitative
Cooper SJ~Fields S, 2010 abundance of glutamate standard SC hap a 4,276 Quantitative
Cooper SJ~Fields S, 2010 abundance of aspartic acid standard SC hap a 3,963 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [o/n + 20 gen] SC - Lys hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [o/n + 5 gen] SC - Lys hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [o/n + 15 gen] SC hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [o/n + 20 gen] SC hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [o/n + 5 gen] SC hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [o/n + 5 gen] SC - Thr hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [o/n + 15 gen] SC - Trp hom 4,742 Quantitative
Hillenmeyer ME~Giaever G, 2008 growth (relative abundance in pooled culture) time [o/n + 5 gen] SC - Trp hom 4,742 Quantitative
Powers RW 3rd~Fields S, 2006 chronological lifespan time [1 w] SC hom 4,714 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) cadmium dichloride [75 uM], time [24 h] SC hap a 4,720 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) sodium arsenite [0.5 mM], time [24 h] SC hap a 4,786 Quantitative
Fabrizio P~Longo VD, 2010 chronological lifespan time [9 d] SC + 4(Trp, Leu, Ura, His) hap a 4,130 Quantitative
Powers RW 3rd~Fields S, 2006 chronological lifespan time [2 w] SC hom 4,714 Quantitative
Powers RW 3rd~Fields S, 2006 chronological lifespan time [5 w] SC hom 4,714 Quantitative
Powers RW 3rd~Fields S, 2006 chronological lifespan time [7 w] SC hom 4,714 Quantitative
Fabrizio P~Longo VD, 2010 chronological lifespan time [11 d] SC + 4(Trp, Leu, Ura, His) hap a 4,130 Quantitative
Fabrizio P~Longo VD, 2010 chronological lifespan time [15 d] SC + 4(Trp, Leu, Ura, His) hap a 4,130 Quantitative
Fabrizio P~Longo VD, 2010 chronological lifespan time [20 d] SC + 4(Trp, Leu, Ura, His) hap a 4,130 Quantitative
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) 5-fluorouracil [2 uM] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) actinomycin D [20 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) amitriptyline [125 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) amphotericin B [600 ng/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) cytarabine [500 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) asulam [250 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) atenolol [4 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) zidovudine [2 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) oxybuprocaine [900 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) caffeine [700 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) camptothecin [100 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) carbendazim [100 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) chlorpromazine [37.5 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) cisplatin [600 uM] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) clomipramine [50 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) clotrimazole [37.5 ng/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) cycloheximide [10 ng/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) cymoxanil [1.25 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) daunorubicin [40 ng/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) desipramine [200 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) diltiazem [2 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) dimethyl sulfoxide [2.5%] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) doxorubicin [3 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) doxycycline [400 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) dyclonine [32 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) efavirenz [300 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) Erythromycin ethylsuccinate [2.5 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) ethanol [1.25%] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) fenpropimorph [0.00001%] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) flurbiprofen [75 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) gemfibrozil [30 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) gliotoxin [3 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) haloperidol [62.5 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) histamine [3 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) hydroxyurea [20 mM] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) ibuprofen [10 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) imipramine [312.5 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) indometacin [100 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) isoniazide [275 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) kanamycin [6 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) lovastatin [40 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) menadione [40 ng/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) methotrexate [12.5 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) methyl methanesulfonate [0.002%] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) metoclopramide [7 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) Molsidomine [2 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) nalidixic acid [325 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) naproxen [40 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) nevirapine [250 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) Nicardipine [1 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) nifedipine [200 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) nitrofurantoin [500 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) omeprazole [50 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) paromomycin [5 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) pentamidine [250 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) phenylbutazone [200 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) pramoxine [16 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) procaine [2.5 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) promethazine [100 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) sodium arsenite [20 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) sodium chloride [250 mM] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) sodium nitroprusside [667 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) staurosporine [2 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) sulfamethoxazole [200 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) sulfanilamide [625 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) sulfinpyrazone [20 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) sulfometuron methyl [1.25 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) tamoxifen [3.5 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) terbinafine [2.5 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) tetracycline [800 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) thalidomide [1 mg/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) trifluoperazine [17.5 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) troglitazone [300 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) tunicamycin [150 ng/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) valproic acid [300 ug/ml] SC het 3,503 Quantitative only for hits
Lum PY~Shoemaker DD, 2004 growth (relative abundance in pooled culture) warfarin [500 ug/ml] SC het 3,503 Quantitative only for hits
Wilson WA~Roach PJ, 2002 accumulation of glycogen (iodine staining) standard SC hom 4,621 Discrete
Thorpe GW~Dawes IW, 2004 growth (spot assay) menadione [0.5–1.2 mM] SC hom ~4,546 Discrete
Thorpe GW~Dawes IW, 2004 growth (spot assay) linoleic acid hydroperoxide [0.045–0.08 mM] SC hom ~4,546 Discrete
Deranieh RM~Greenberg ML, 2015 growth (spot assay) valproate [2-6 mM] SC hap a ~4,815 Discrete
Thorpe GW~Dawes IW, 2004 growth (spot assay) diamide SC hom ~4,546 Discrete
Thorpe GW~Dawes IW, 2004 growth (spot assay) cumene hydroperoxide [0.035–0.11 mM] SC hom ~4,546 Discrete
Yazawa H~Uemura H, 2007 growth (spot assay) ethanol [8%] SC hom ~4,741 Discrete
Zakrzewska A~Klis FM, 2007 growth (culture turbidity) chitosan [25 ug/ml], time [5 h] SC het 1,073 Quantitative
Zakrzewska A~Klis FM, 2007 growth (culture turbidity) chitosan [25 ug/ml], time [9 h] SC het 1,070 Quantitative
Singh-Babak SD~Cowen LE, 2012 growth (relative abundance in pooled culture) cyclosporin A [10 uM], time [20 gen] SC het 1,069 Quantitative
Singh-Babak SD~Cowen LE, 2012 growth (relative abundance in pooled culture) cyclosporin A [10 uM], time [5 gen] SC hom 4,416 Quantitative
Singh-Babak SD~Cowen LE, 2012 growth (relative abundance in pooled culture) micafungin [0.045 ug/ml], time [20 gen] SC het 1,069 Quantitative
Singh-Babak SD~Cowen LE, 2012 growth (relative abundance in pooled culture) micafungin [0.045 ug/ml], time [5 gen] SC hom 4,416 Quantitative
Singh-Babak SD~Cowen LE, 2012 growth (relative abundance in pooled culture) cyclosporin A [10 uM], micafungin [0.045 ug/ml], time [20 gen] SC het 1,069 Quantitative
Singh-Babak SD~Cowen LE, 2012 growth (relative abundance in pooled culture) cyclosporin A [10 uM], micafungin [0.045 ug/ml], time [5 gen] SC hom 4,416 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) sodium arsenite [1 mM], time [24 h] SC hap a 4,786 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) sodium arsenite [1.5 mM], time [24 h] SC hap a 4,786 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) sodium arsenite [0.5 mM], time [48 h] SC hap a 4,786 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) sodium arsenite [1 mM], time [48 h] SC hap a 4,786 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) sodium arsenite [1.5 mM], time [48 h] SC hap a 4,786 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) cadmium dichloride [100 uM], time [24 h] SC hap a 4,720 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) cadmium dichloride [150 uM], time [24 h] SC hap a 4,720 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) cadmium dichloride [75 uM], time [48 h] SC hap a 4,754 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) cadmium dichloride [100 uM], time [48 h] SC hap a 4,754 Quantitative
Thorsen M~Tamas MJ, 2009 growth (spot assay) cadmium dichloride [150 uM], time [48 h] SC hap a 4,754 Quantitative
Choi J~O'Shea EK, 2017 expression level of a gene (PHO84pr-YFP) inorganic phosphate [50 uM] SC hap a 4,517 Quantitative
Choi J~O'Shea EK, 2017 expression level of a gene (PHO84pr-YFP) inorganic phosphate [1 mM] SC hap a 4,507 Quantitative
Nair S~Perrone GG, 2014 expression of human amyloid-beta peptide isoform 42 (Ab42-GFP) expression of amyloid-beta 42 [unknown] SC - Ura, Gal [2%] hom ~4,600 Discrete
Ruggles KV~Sturley SL, 2014 growth (colony size) palmitoleate [0.5 mM] SC hap alpha ~4,800 Quantitative only for hits
Pir P~Oliver SG, 2012 growth (relative abundance in pooled culture) culture dilution rate [0.3/h] SC het 5,580 Quantitative
Pir P~Oliver SG, 2012 growth (relative abundance in pooled culture) turbidostat SC het 5,580 Quantitative
Panavas T~Nagy PD, 2005 viral RNA replication (DI-72(+) RNA) standard SC - His - Leu - Ura, G418, Gal [2%] hap a ~4,548 Quantitative only for hits
Tyedmers J~Lindquist S, 2008 growth (general) overexpression of the [PSI+] prion [GAL for 3 d at 30C] SC - Ura, Gal [2%] hap a ~4,700 Discrete
Sun Z~Gitler AD, 2011 growth (colony size) expression of human FUS [GAL] SC - Ura, Gal [2%] hap a ~4,850 Discrete
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) standard SC hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) sodium chloride [0.2 M] SC hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) salt stress oscillation SC hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) standard SC - Met hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) methionine [1 mM] SC - Met hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) methionine oscillation SC - Met hom 3,540 Quantitative
Campos SE~DeLuna A, 2018 chronological lifespan nonrestricted diet medium SC hap alpha 3,696 Quantitative
Campos SE~DeLuna A, 2018 chronological lifespan dietary-restricted medium SC hap alpha 3,696 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) salt stress oscillation SC hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) salt stress oscillation SC hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) salt stress oscillation SC hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) salt stress oscillation SC hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) methionine oscillation SC - Met hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) methionine oscillation SC - Met hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) methionine oscillation SC - Met hom 3,540 Quantitative
Salignon J~Yvert G, 2018 growth (relative abundance in pooled culture) methionine oscillation SC - Met hom 3,540 Quantitative
Warringer J~Blomberg A, 2003 growth (exponential growth rate) standard SC hap a 4,711 Quantitative
Warringer J~Blomberg A, 2003 growth (lag phase) standard SC hap a 4,711 Quantitative
Warringer J~Blomberg A, 2003 growth (stationary phase cell density) standard SC hap a 4,704 Quantitative
Hartman JL 4th~Tippery NP, 2004 growth (AUC) standard SC hap a 4,757 Quantitative
Villa-Garcia MJ~Henry SA, 2011 growth (spot assay) temperature [30°C] SC - Ino - Cho hom ~4,741 Discrete
Villa-Garcia MJ~Henry SA, 2011 growth (spot assay) temperature [30°C] SC - Ino + Cho hom ~4,741 Discrete
Villa-Garcia MJ~Henry SA, 2011 growth (spot assay) temperature [37ºC] SC - Ino + Cho hom ~4,741 Discrete